James K.

James K. is a seasoned financial executive currently serving as Chief Financial Officer at EarSwitch, 1nhaler, and BDD since 2024 and also as CEO of JGK Financial Management Ltd since 2017. With extensive experience in financial leadership, James has previously held key roles such as Interim Chief Financial Officer at WASE LIMITED and Board Governance & CFO at Keltic Pharma Therapeutics. Notably, James contributed as CFO at Stevenage Bioscience Catalyst, fostering a life sciences ecosystem, and held various roles at Colt Technology Services and BT, building expertise in commercial finance and operations. James's foundation in finance was developed during tenure at GSK, focusing on R&D and commercial operations in virology and oncology. James's academic credentials include degrees from Saïd Business School at the University of Oxford, The London School of Economics and Political Science, and the University of Cambridge.